Understanding how enzymes repair proteins affected by sugar modifications
Biophysical basis for enzyme mediated deglycation in protein repair
This study is looking at how a special enzyme helps fix proteins that have been damaged by sugar, which can lead to health issues like Alzheimer's, diabetes, and heart disease, so that we can find better ways to prevent or treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11044039 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which enzymes repair proteins that have undergone glycation, a process where sugars attach to proteins, potentially leading to various diseases. The study focuses on a specific enzyme called Fructosamine-3-kinase (FN3K), which plays a crucial role in reversing early glycation events. By exploring how these protein modifications affect diseases like Alzheimer's, diabetes, and atherosclerosis, the research aims to provide insights into potential therapeutic targets. Patients may benefit from a better understanding of how to prevent or treat conditions related to protein glycation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions such as diabetes, Alzheimer's disease, or other age-related diseases linked to protein glycation.
Not a fit: Patients with conditions unrelated to protein glycation or those who do not have the aforementioned diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating diseases associated with protein glycation, improving patient outcomes.
How similar studies have performed: While the specific approach of studying FN3K is relatively novel, there is existing research indicating that targeting protein modifications can lead to meaningful advancements in treating related diseases.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Binning, Jennifer — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Binning, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.